| Genetic Predictors for Fecal Propionate and Butyrate-Producing Microbiome Pathway Are Not Associated with Colorectal Cancer Risk: A Mendelian Randomization Analysis. |
36512731
|
Lu Y
, Zhao YC
, Chang-Claude J
, Gruber SB
, Gsur A
, Offit K
, Vodickova L
, Woods MO
, Nguyen LH
, Wade KH
, Carreras-Torres R
, Moreno V
, Buchanan DD
, Cotterchio M
, Chan AT
, Phipps AI
, Peters U
, Song M |
Cancer Epidemiol Biomarkers Prev |
2023 |
PLCO |
| Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. |
36843273
|
Chang VC, Rhee J, Berndt SI, Moore SC, Freedman ND, Jones RR, Silverman DT, Gierach GL, Hofmann JN, Purdue MP |
Int J Cancer |
2023 |
PLCO |
| A Metabolomic Signature of Obesity and Risk of Colorectal Cancer: Two Nested Case-Control Studies. |
36837854
|
Yang M, Zhu C, Du L, Huang J, Lu J, Yang J, Tong Y, Zhu M, Song C, Shen C, Dai J, Lu X, Xu Z, Li N, Ma H, Hu Z, Gu D, Jin G, Hang D, Shen H |
Metabolites |
2023 |
PLCO |
| Body mass index and molecular subtypes of colorectal cancer. |
36445035
|
Murphy N
, Newton CC
, Song M
, Papadimitriou N
, Hoffmeister M
, Phipps AI
, Harrison TA
, Newcomb PA
, Aglago EK
, Berndt SI
, Brenner H
, Buchanan DD
, Cao Y
, Chan AT
, Chen X
, Cheng I
, Chang-Claude J
, Dimou N
, Drew D
, Farris AB
, French AJ… |
J Natl Cancer Inst |
2023 |
PLCO |
| A prospective nested case-control study of serum concentrations of per- and polyfluoroalkyl substances and aggressive prostate cancer risk. |
36958379
|
Rhee J, Barry KH, Huang WY, Sampson JN, Hofmann JN, Silverman DT, Calafat AM, Botelho JC, Kato K, Purdue MP, Berndt SI |
Environ Res |
2023 |
PLCO |
| Explainable discovery of disease biomarkers: The case of ovarian cancer to illustrate the best practice in machine learning and Shapley analysis. |
37062419
|
Huang W, Suominen H, Liu T, Rice G, Salomon C, Barnard AS |
J Biomed Inform |
2023 |
PLCO |
| Association between dietary approaches to stop hypertension eating pattern and lung cancer risk in 98,459 participants: results from a large prospective study. |
37255940
|
Zhu Z, Peng L, Gu H, Tang Y, Xiao Y, He H, Yang M, Xiang L, Wang Y |
Front Nutr |
2023 |
PLCO |
| Multi-Label Local to Global Learning: A Novel Learning Paradigm for Chest X-ray Abnormality Classification. |
37252867
|
Liu Z, Cheng Y, Tamura S |
IEEE J Biomed Health Inform |
2023 |
PLCO |
| Liver cancer risk quantification through an artificial neural network based on personal health data. |
37211681
|
Ataei A, Deng J, Muhammad W |
Acta Oncol |
2023 |
PLCO |
| Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. |
37210288
|
Koutros S, Kiemeney LA, Pal Choudhury P, Milne RL, Lopez de Maturana E, Ye Y, Joseph V, Florez-Vargas O, Dyrskjøt L, Figueroa J, Dutta D, Giles GG, Hildebrandt MAT, Offit K, Kogevinas M, Weiderpass E, McCullough ML, Freedman ND, Albanes D, Kooperber… |
Eur Urol |
2023 |
PLCO |
| Lipidomics and pancreatic cancer risk in two prospective studies. |
37169992
|
Naudin S, Sampson JN, Moore SC, Albanes D, Freedman ND, Weinstein SJ, Stolzenberg-Solomon R |
Eur J Epidemiol |
2023 |
PLCO |
| Analysis of Body Mass Index in Early and Middle Adulthood and Estimated Risk of Gastrointestinal Cancer. |
37163267
|
Loomans-Kropp HA, Umar A |
JAMA Netw Open |
2023 |
PLCO |
| Quantifying the Contributions of Environmental Factors to Prostate Cancer and Detecting Risk-Related Diet Metrics and Racial Disparities. |
37139178
|
Zhang W, Zhang K |
Cancer Inform |
2023 |
PLCO |
| A nested case-control study of untargeted albumin adductomics and acute myeloid leukemia. |
37138425
|
Rahman ML, Bassig BA, Grigoryan H, Hu W, Hosgood HD, Huang WY, Wong JYY, Strickland P, Rappaport SM, Lan Q, Rothman N |
Int J Cancer |
2023 |
PLCO |
| Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial. |
37384841
|
Yim K, Ma C, Carlsson S, Lilja H, Mucci L, Penney K, Kibel AS, Eggener S, Preston MA |
J Urol |
2023 |
PLCO |
| Obesity and prostate cancer screening, incidence, and mortality in the PLCO Cancer Screening Trial. |
37382561
|
Hurwitz LM, Dogbe N, Hughes Barry K, Koutros S, Berndt SI |
J Natl Cancer Inst |
2023 |
PLCO |
| Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort. |
37379494
|
Irajizad E, Fahrmann JF, Marsh T, Vykoukal J, Dennison JB, Long JP, Do KA, Feng Z, Hanash S, Ostrin EJ |
J Clin Oncol |
2023 |
PLCO |
| Dietary glycemic index, glycemic load, and renal cancer risk: findings from prostate, lung, colorectal, and ovarian cancer trial. |
37346909
|
Qi H, Xia D, Xu X |
Front Nutr |
2023 |
PLCO |
| Low-fat dairy consumption and the risk of lung cancer: A large prospective cohort study. |
37329182
|
Zhu Z, Peng L, Zhou H, Gu H, Tang Y, Zhou Z, Xiang L, Wang Y |
Cancer Med |
2023 |
PLCO |
| Associations of Dietary Patterns with Colorectal Adenomas in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Cohort. |
37327041
|
Nepal S, Aslani Z, Shi N, Tabung FK |
Cancer Epidemiol Biomarkers Prev |
2023 |
PLCO |
